SEC Form 4
AdaptHealth Corp. (AHCO) insider trading
In the 12 months to Nov 18, 2026, 2 AHCO insiders reported open-market sales of $278.3K across 3 filings; 4 insiders bought $24.9M.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $278.3K
- 3 filings · 2 insiders
- Open-market purchases
- $24.9M
- 7 filings
- Pre-arranged sales (10b5-1)
- 2 of 3
- $231.1K of $278.3K sold (83%)
Who traded AHCO, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
AHCO daily close from Nov 18, 2025 to Nov 17, 2026, between $5.22 and $13.38, last $7.53. 3 sale and 7 purchase filings by 6 insiders, marked at their filing dates. Richard M. Cashin Jr., 10% owner: bought $24.4M across 2 filings, first filed Mar 30, 2026, last Mar 30, 2026. Dale B. Wolf, Director: bought $314.9K across 3 filings, first filed Mar 3, 2026, last Aug 14, 2026. III Russell E. Schuster, Chief Commercial Officer: sold $231.1K across 2 filings, first filed Jun 3, 2026, last Jul 6, 2026. Kenneth A. Samet, Director: bought $149.9K across 1 filing, first filed Aug 10, 2026, last Aug 10, 2026. David Solomon Williams III, Director: sold $47.2K across 1 filing, first filed Dec 5, 2025, last Dec 5, 2025. Richard W. Rew II, CLO and General Counsel: bought $44.6K across 1 filing, first filed Feb 27, 2026, last Feb 27, 2026.
Largest mark · tap a row for others
Richard M. Cashin Jr. · 10% owner
Filing 1 of 2 within a week · $24,351,075 total
Purchase $19,912,148
2,046,691 shares at $9.73 avg
Filed Mar 30, 2026 · traded Mar 10
Close on filing date $11.29
Richard M. Cashin Jr. · 10% owner
10% owner
$24.4M boughtDale B. Wolf · Director
Director
$314.9K boughtIII Russell E. Schuster · Chief Commercial Officer
Chief Commercial Officer
$231.1K soldKenneth A. Samet · Director
Director
$149.9K boughtDavid Solomon Williams III · Director
Director
$47.2K soldRichard W. Rew II · CLO and General Counsel
CLO and General Counsel
$44.6K boughtOpen-market trades
10 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Richard M. Cashin Jr. | 10% owner | — | $24.4M | 2 | — | |
| Dale B. Wolf | Director | — | $314.9K | 3 | — | |
| III Russell E. Schuster | Chief Commercial Officer | $231.1K | — | 2 | 100% of sales | |
| Kenneth A. Samet | Director | — | $149.9K | 1 | — | |
| David Solomon Williams III | Director | $47.2K | — | 1 | — | |
| Richard W. Rew II | CLO and General Counsel | — | $44.6K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Dale B. Wolf Director | Purchase | 20,000 | $6.30 | $126.0K | 143,234 | |
traded | Dale B. Wolf Director | Purchase | 20,000 | $5.86 | $117.2K | 34,000 | |
traded | Kenneth A. Samet Director | Purchase | 23,500 | $6.38 | $149.9K | 48,569 | |
traded | III Russell E. Schuster Chief Commercial Officer | SalePre-arranged (10b5-1) | 11,275 | $10.44 | $117.7K | 125,263 | |
traded | III Russell E. Schuster Chief Commercial Officer | SalePre-arranged (10b5-1) | 11,275 | $10.06 | $113.4K | 136,538 | |
traded | Richard M. Cashin Jr. 10% owner | Purchase | 2,046,691 | $9.73 | $19.9M | 15,864,871 | |
traded | Richard M. Cashin Jr. 10% owner | Purchase | 447,827 | $9.91 | $4.4M | 16,312,698 | |
traded | Dale B. Wolf Director | Purchase | 8,000 | $8.96 | $71.7K | 104,235 | |
traded | Richard W. Rew II CLO and General Counsel | Purchase | 5,000 | $8.91 | $44.6K | 107,097 | |
traded | David Solomon Williams III Director | Sale | 5,000 | $9.43 | $47.2K | 45,045 |
GET /stocks/filings/vX/form-4?tickers=AHCO&filing_date.gte=2025-11-18&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"AHCO"
],
"issuer_cik": "0001725255",
"owner_cik": "0001228861",
"accession_number": "0001104659-26-097053",
"form_type": "4/A",
"filing_date": "2026-08-14",
"period_of_report": "2026-08-06",
"issuer_name": "AdaptHealth Corp.",
"issuer_trading_symbol": "AHCO",
"owner_name": "WOLF DALE B",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-06",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 6.3,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 143234,
"transaction_value": 126000,
"date_of_original_submission": "2026-08-10",
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1)."
}
],
"remarks": "*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference."
},
{
"tickers": [
"AHCO"
],
"issuer_cik": "0001725255",
"owner_cik": "0001228861",
"accession_number": "0001104659-26-093575",
"form_type": "4",
"filing_date": "2026-08-10",
"period_of_report": "2026-08-06",
"issuer_name": "AdaptHealth Corp.",
"issuer_trading_symbol": "AHCO",
"owner_name": "WOLF DALE B",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-06",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 6.37,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 143234,
"transaction_value": 127400,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"remarks": "*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference."
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 25 records
- Option exercises1 record
- Tax withholding1 record
- Grants and awards21 records
- Gifts2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has AdaptHealth Corp.'s CEO sold stock?
No. Suzanne Foster (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is AHCO’s insider data?
These are AHCO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track AHCO insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for AHCO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.